[ACS] HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies

 关闭 求助已关闭
PJL2025 发表于 2026-9-11 15:53:25 | 显示全部楼层 |阅读模式
悬赏10积分

期刊:Journal of Medicinal Chemistry

文献作者:A. Elisa Pasqua; Swee Y. Sharp; Nicola E. A. Chessum; Angela Hayes; Loredana Pellegrino; Michael J. Tucker; Asadh Miah; Birgit Wilding; Lindsay E. Evans; Carl S. Rye; N. Yi Mok; Manjuan Liu; Alan T. Henley; Sharon Gowan; Emmanuel De Billy; Robert te Poele; Marissa Powers; Suzanne A. Eccles; Paul A. Clarke; Florence I. Raynaud; Paul Workman; Keith Jones; Matthew D. Cheeseman

出版日期:2023-4-27

DOI号:10.1021/acs.jmedchem.3c00156

下载链接:https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00156

文献链接:https://doi.org/10.1021/acs.jmedchem.3c00156

当前文献来源于 American Chemical Society (ACS)。


备注信息:
全部回复0 显示全部楼层

发表回复

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

VIP会员
  • 发布

  • 回复

  • 积分

    640

返回列表